DefaultUser

Staff Physician II, Division of Gastroenterology, Hepatology and Nutrition

513-636-4415

Board Certified

About Me

Clinical Interests

Pediatric gastroenterology; non-alcoholic steatohepatitis

Divisions

Gastroenterology GI, Steatohepatitis

My Locations

My Education

BS: Stanford University, Stanford, CA, 2000.

MD: University of Cincinnati, Cincinnati, OH, 2006.

Residency: Schneider Children’s Hospital (Renamed Cohen Children’s Medical Center of New York), New Hyde Park, NY, 2009.

Chief Residency: Pediatrics, Schneider Children’s Hospital (Renamed Cohen Children’s Medical Center of New York), New Hyde Park, NY, 2010.

Fellowship: Pediatric Gastroenterology, Cincinnati Children's Hospital Medical Center, 2013.

My Publications

Vitamin D deficiency: prevalence and association with liver disease severity in pediatric nonalcoholic fatty liver disease. Yodoshi, T; Orkin, S; Arce-Clachar, AC; Bramlage, K; Liu, C; Fei, L; El-Khider, F; Dasarathy, S; Xanthakos, SA; Mouzaki, M. European Journal of Clinical Nutrition. 2020; 74:427-435.

Community Socioeconomic Deprivation and Nonalcoholic Fatty Liver Disease Severity. Orkin, S; Brokamp, C; Yodoshi, T; Trout, AT; Liu, C; Meryum, S; Taylor, S; Wolfe, C; Sheridan, R; Seth, A; et al. Journal of Pediatric Gastroenterology and Nutrition. 2020; 70:364-370.

Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease. Seth, A; Orkin, S; Yodoshi, T; Liu, C; Fei, L; Hardy, J; Trout, AT; Arce Clachar, A; Bramlage, K; Xanthakos, S; et al. Pediatric Obesity. 2020; 15.

Psychotropic Medications Are Associated with Increased Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. Mouzaki, M; Yodoshi, T; Arce-Clachar, AC; Bramlage, K; Fei, L; Ley, SL; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2019; 69:339-343.

Extremely low levels of low-density lipoprotein potentially suggestive of familial hypobetalipoproteinemia: A separate phenotype of NAFLD?. Mouzaki, M; Shah, A; Arce-Clachar, AC; Hardy, J; Bramlage, K; Xanthakos, SA. Journal of Clinical Lipidology. 2019; 13:425-431.

Serum Immunoglobulin A Levels Do Not Correlate With Liver Disease Severity in Pediatric Nonalcoholic Fatty Liver Disease. Mouzaki, M; Bramlage, K; Arce-Clachar, AC; Xanthakos, SA. Journal of Pediatric Gastroenterology and Nutrition. 2018; 67:631-634.

Assessment of Nonalcoholic Fatty Liver Disease Progression in Children Using Magnetic Resonance Imaging. Mouzaki, M; Trout, AT; Arce-Clachar, AC; Bramlage, K; Kuhnell, P; Dillman, JR; Xanthakos, S. The Journal of Pediatrics. 2018; 201:86-92.

Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease. Harlow, KE; Africa, JA; Wells, A; Belt, PH; Behling, CA; Jain, AK; Molleston, JP; Newton, KP; Rosenthal, P; Vos, MB; et al. The Journal of Pediatrics. 2018; 198:76-83.e2.

In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. Africa, JA; Behling, CA; Brunt, EM; Zhang, N; Luo, Y; Wells, A; Hou, J; Belt, PH; Kohil, R; Lavine, JE; et al. Clinical Gastroenterology and Hepatology. 2018; 16:438-446.e1.

Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?. Dillman, JR; Trout, AT; Costello, EN; Serai, SD; Bramlage, KS; Kohli, R; Xanthakos, SA. American Journal of Roentgenology. 2018; 210:166-174.